Detailed information for compound 1848488

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 404.46 | Formula: C22H17FN4OS
  • H donors: 2 H acceptors: 3 LogP: 4.43 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CSc1nc(c([nH]1)c1ccnc(c1)NC(=O)c1ccccc1)c1ccc(cc1)F
  • InChi: 1S/C22H17FN4OS/c1-29-22-26-19(14-7-9-17(23)10-8-14)20(27-22)16-11-12-24-18(13-16)25-21(28)15-5-3-2-4-6-15/h2-13H,1H3,(H,26,27)(H,24,25,28)
  • InChiKey: YTUSPQSXAGPIOT-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens mitogen-activated protein kinase 14 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Trypanosoma congolense mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania donovani mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma cruzi mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania infantum mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Brugia malayi P38 map kinase family protein 2 Get druggable targets OG5_128610 All targets in OG5_128610
Candida albicans MAP kinase involved in osmoregulation Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma brucei gambiense mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Schistosoma japonicum ko:K04441 p38 MAP kinase, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma brucei mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Loa Loa (eye worm) CMGC/MAPK/P38 protein kinase Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus granulosus mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania mexicana mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Candida albicans MAP kinase involved in osmoregulation Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania major mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus granulosus mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma cruzi mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania braziliensis mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 14 360 aa 336 aa 33.3 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis mitogen activated protein kinase 11 0.0152 0.5389 0.5
Toxoplasma gondii beta-ketoacyl synthase, N-terminal domain-containing protein 0.0085 0.2149 0.2574
Echinococcus multilocularis mitogen activated protein kinase 11 0.0152 0.5389 0.5
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB 0.0105 0.3131 0.4155
Toxoplasma gondii type I fatty acid synthase, putative 0.0139 0.4752 1
Mycobacterium ulcerans thioesterase TesA 0.0109 0.3311 0.443
Mycobacterium tuberculosis Probable multifunctional mycocerosic acid synthase membrane-associated Mas 0.0139 0.4752 0.6357
Echinococcus granulosus mitogen activated protein kinase 11 0.0152 0.5389 0.5
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsE 0.0086 0.2228 0.2981
Mycobacterium tuberculosis Probable polyketide synthase Pks7 0.0139 0.4752 0.6357
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsD 0.0131 0.4361 0.5834
Mycobacterium ulcerans Type I modular polyketide synthase 0.0131 0.4361 0.5834
Trypanosoma cruzi mitogen-activated protein kinase 3, putative 0.0152 0.5389 0.5
Mycobacterium leprae PROBABLE THIOESTERASE TESA 0.0109 0.3311 0.4398
Mycobacterium ulcerans thioesterase 0.0109 0.3311 0.443
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsA 0.0105 0.3131 0.4188
Loa Loa (eye worm) hypothetical protein 0.0073 0.1592 0.0823
Mycobacterium tuberculosis Probable polyketide synthase Pks8 0.0107 0.3214 0.4299
Onchocerca volvulus Fatty acid synthase homolog 0.0236 0.9416 1
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsD 0.0131 0.4361 0.5834
Trypanosoma cruzi mitogen-activated protein kinase 3, putative 0.0152 0.5389 0.5
Mycobacterium tuberculosis Probable polyketide synthase Pks15 0.0053 0.061 0.0817
Mycobacterium tuberculosis Probable polyketide synthase Pks5 0.0127 0.4168 0.5576
Mycobacterium leprae Polyketide synthase Pks13 0.0195 0.7476 1
Mycobacterium tuberculosis Probable thioesterase TesA 0.0109 0.3311 0.443
Trypanosoma brucei mitogen-activated protein kinase 3, putative 0.0152 0.5389 0.5
Loa Loa (eye worm) AMP-binding enzyme family protein 0.0122 0.3948 0.3889
Mycobacterium ulcerans Type I modular polyketide synthase 0.0131 0.4361 0.5834
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsC 0.0139 0.4752 0.6357
Mycobacterium ulcerans multifunctional mycocerosic acid synthase membrane-associated Mas 0.0139 0.4752 0.6357
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC 0.0139 0.4752 0.6337
Mycobacterium tuberculosis Polyketide synthase Pks2 0.0127 0.4168 0.5576
Mycobacterium tuberculosis Probable polyketide synthase Pks9 0.0074 0.1644 0.2199
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD 0.0131 0.4361 0.581
Onchocerca volvulus 0.0228 0.9025 0.9285
Mycobacterium ulcerans polyketide synthase Pks9 0.0086 0.2228 0.2981
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsC 0.0131 0.4361 0.5834
Mycobacterium tuberculosis Polyketide synthetase MbtC (polyketide synthase) 0.0045 0.0229 0.0306
Leishmania major mitogen-activated protein kinase 3, putative,map kinase 3, putative 0.0152 0.5389 0.5
Mycobacterium leprae Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas 0.0139 0.4752 0.6337
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE 0.0086 0.2228 0.2941
Brugia malayi AMP-binding enzyme family protein 0.0122 0.3948 0.3948
Echinococcus multilocularis mitogen activated protein kinase 14 0.0152 0.5389 0.5
Mycobacterium ulcerans polyketide synthase 0.0139 0.4752 0.6357
Loa Loa (eye worm) hypothetical protein 0.022 0.8643 1
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsB 0.0105 0.3131 0.4188
Echinococcus granulosus mitogen activated protein kinase 14 0.0152 0.5389 0.5
Mycobacterium ulcerans polyketide synthase Pks13 0.0195 0.7476 1
Mycobacterium ulcerans fatty acid synthase Fas 0.0041 0.0042 0.0056
Mycobacterium tuberculosis Probable fatty acid synthase Fas (fatty acid synthetase) 0.0041 0.0042 0.0056
Brugia malayi Beta-ketoacyl synthase, N-terminal domain containing protein 0.0131 0.4361 0.4361
Loa Loa (eye worm) fatty acid synthase 0.0129 0.4277 0.4318
Mycobacterium tuberculosis Polyketide synthase Pks12 0.0139 0.4752 0.6357
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA 0.0131 0.4361 0.581
Mycobacterium ulcerans polyketide synthase 0.0131 0.4361 0.5834
Mycobacterium tuberculosis Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) 0.0122 0.3948 0.528
Mycobacterium tuberculosis Probable polyketide synthase Pks1 0.0094 0.2588 0.3461
Mycobacterium tuberculosis Polyketide synthase Pks13 0.0195 0.7476 1
Brugia malayi P38 map kinase family protein 2 0.0152 0.5389 0.5389
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsA 0.0131 0.4361 0.5834
Mycobacterium tuberculosis Probable membrane bound polyketide synthase Pks6 0.0195 0.7476 1
Mycobacterium leprae Probable polyketide synthase Pks1 0.0139 0.4752 0.6337
Echinococcus multilocularis mitogen activated protein kinase 14 0.0152 0.5389 0.5
Mycobacterium ulcerans Type I modular polyketide synthase 0.0131 0.4361 0.5834
Toxoplasma gondii type I fatty acid synthase, putative 0.0093 0.2547 0.3708
Loa Loa (eye worm) CMGC/MAPK/P38 protein kinase 0.0152 0.5389 0.5765

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.019 uM Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs ChEMBL. No reference
Ratio IC50 (binding) = 1.36 Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.